SubscribeSign In

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

https://www.wsj.com/articles/blood-test-customers-mistakenly-told-they-may-have-cancer-31baf9ea

Blood-Test Customers Mistakenly Told They May Have Cancer

Grail said its telemedicine vendor sent inaccurate forms because of a software glitch

By Peter Loftus
Grail, a developer of multi-cancer early-detection blood tests, says about 400 customers were notified mistakenly that they may have the disease. Photo: Grail Inc./Associated Press

Cancer blood-test maker Grail said about 400 customers were mistakenly notified that its test detected a cancer signal in them, which the company attributed to a partner’s software glitch.

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue reading your article with
a WSJ subscription

Subscribe Now

Already a subscriber? Sign In

Sponsored Offers
  • The Wall Street Journal
  • Sign In
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Podcasts
  • Snapchat
  • Google Play
  • App Store
  • Privacy Notice
  • Cookie Notice
  • Copyright Policy
  • Data Policy
  • Subscriber Agreement & Terms of Use
  • Your Ad Choices
  • Accessibility
  • Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved.
  • Google Play
  • App Store
Sign In
Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved.

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.